Navigation Links
There's a new dynamic in the stem cell debate

Madison, Wis. - The United States Catholic Bishops did not waver, and after some initial signs of hesitation, neither did the White House.

Wisconsin Right to Life, however, is not yet prepared to rule out a new method of deriving stem cells from human embryos that does not d......

Full article >>> the Green Campaign, said the Republican gubernatorial candidate is encouraged by the news. "He thinks this is a very promising development in stem cell research, and it's clear that we may be able to conduct this research without grappling with some of these signficant ethical questions," Punzenberger said.

New method

Researchers believe human embryonic stem cell research ......

Full article >>> gy is successful in securing a patent for its method of deriving stem cells when WARF not only holds patents for its method, derived by University of Wisconsin-Madison researcher James Thomson, but also a composition-of-matter patent on all embryonic stem cells?

WARF manages inventions by UW-Madison professors and claims United States patents on all human......

Full article >>> undation for Taxpayer and Consumer Rights, believes they would. "They would claim the right to human embryonic stem cell patents derived in this [new] way," Simpson stated.

He also said the new method of deriving stem cells doesn't make the WARF patent a moot point because it hasn't been replicated elsewhere, and the research community still isn't sure how robust it is.

"It's......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 08/24/06


Related biology technology :

1. siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005)
2. Misconceptions dominate the immigration debate
3. Candidates sparring over jobs focuses debate on right issue
4. A brief timeline of the stem cell debate
5. Employees debate ethics of giving two weeks notice
6. Stem-cell debate, wireless access and other endeavors heat up
7. Separating science fiction from reality in the human cloning debate
8. Stem cell debate in Washington grows hotter as summer recess nears
9. Theres a surprising, and positive, side to the offshore jobs debate
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... ... Services portfolio to include an array of biochemical analyses critical for Lead ... to drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill ... a strange place for a head lice treatment salon to ... between a Tuscan restaurant and a French bistro on E ... perfect. "We aren,t just any old lice clinic, we pride ... feel comfortable, and release some of the stigma associated with ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
Breaking Biology Technology:
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):